<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biomol Struct Dyn</journal-id><journal-id journal-id-type="iso-abbrev">J. Biomol. Struct. Dyn</journal-id><journal-title-group><journal-title>Journal of Biomolecular Structure &#x00026; Dynamics</journal-title></journal-title-group><issn pub-type="ppub">0739-1102</issn><issn pub-type="epub">1538-0254</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7441781</article-id><article-id pub-id-type="doi">10.1080/07391102.2020.1798285</article-id><article-id pub-id-type="publisher-id">1798285</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of
Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Identification of some novel oxazine substituted 9-anilinoacridines as
SARS-CoV-2 inhibitors for COVID-19 by molecular docking, free energy calculation and
molecular dynamics studies</article-title><alt-title alt-title-type="left-running-head">K. Rajagopal et al.</alt-title><alt-title alt-title-type="right-running-head">Journal of Biomolecular Structure and
Dynamics</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3382-4316</contrib-id><name><surname>Rajagopal</surname><given-names>Kalirajan</given-names></name><xref ref-type="corresp" rid="AN0001"/><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Varakumar</surname><given-names>Potlapati</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Aparna</surname><given-names>Baliwada</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Byran</surname><given-names>Gowramma</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Jupudi</surname><given-names>Srikanth</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><aff id="AF0001"><institution>Department of Pharmaceutical Chemistry, JSS College of
Pharmacy [A Constituent College of JSS Academy of Higher Education &#x00026;
Research-(Deemed to be University)]</institution>, <city>Ooty</city>,
<state>Tamilnadu</state>, <country>India</country></aff></contrib-group><author-notes><corresp id="AN0001"><bold>CONTACT</bold> Kalirajan Rajagopal <email>rkalirajan@ymail.com</email>; <email>rkalirajan@jssuni.edu.in</email><institution>Department of Pharmaceutical Chemistry,
JSS College of Pharmacy [A Constituent college of JSS Academy of Higher Education &#x00026;
Research-(Deemed to be University)]</institution>, <city>Ooty</city>,
<state>Tamilnadu</state><postal-code>643001</postal-code>, <country>India</country>.</corresp><fn id="AUFN2"><p>Supplemental data for this article can be accessed online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07391102.2020.1798285">https://doi.org/10.1080/07391102.2020.1798285</ext-link>.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>7</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2020</year></pub-date><fpage seq="1">1</fpage><lpage>12</lpage><permissions><copyright-statement>&#x000a9; 2020 Informa UK Limited, trading as Taylor &#x00026; Francis
Group</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Informa UK Limited, trading as Taylor &#x00026; Francis
Group</copyright-holder><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted
re-use and analyses in any form or by any means with acknowledgement of the original
source. These permissions are granted for the duration of the COVID-19 pandemic or until
permissions are revoked in writing. Upon expiration of these permissions, PMC is granted
a perpetual license to make this article available via PMC and Europe PMC, consistent
with existing copyright protections.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="TBSD_0_1798285.pdf"/><abstract><title>Abstract</title><p>Coronavirus disease (COVID-19), a life-threatening disease, is caused by SARS-CoV-2. The
targeted therapeutics of small molecules helps the scientific community to fight against
SARS-CoV-2. In this article, some oxazine substituted 9-anilinoacridines
(<bold>A1&#x02013;A48</bold>) was designed by docking, MM-GBSA and molecular dynamics (MD)
simulation studies for their COVID-19 inhibitory activity. The docking of ligands
<bold>A1&#x02013;A48</bold> against SARS-CoV-2 (PDB ID: 5R82) are performed by using Glide
module, <italic>in silico</italic> ADMET screening by QikProp module, binding
energy using Prime MM-GB/SA module, MD simulation by Desmond module and atomic charges
were derived by Jaguar module of Schrodinger suit 2019-4. Compound <bold>A38</bold> has
the highest G-score (&#x02212;7.83) when compared to all the standard compounds which are proposed
for COVID-19 treatment such as ritonavir (&#x02212;7.48), lopinavir (&#x02212;6.94), nelfinavir (&#x02212;5.93),
hydroxychloroquine (&#x02212;5.47) and mataquine (&#x02212;5.37). Compounds <bold>A13</bold>,
<bold>A23</bold>, <bold>A18</bold>, <bold>A7</bold>, <bold>A48</bold>, <bold>A46</bold>,
<bold>A32</bold>, <bold>A20</bold>, <bold>A1</bold> and <bold>A47</bold> are
significantly active against SARS-CoV-2 main protease when compared with
hydroxychloroquine and mataquine. The residues GLN19, THR24, THR25, THR26, LEU27, HIE41,
SER46, MET49, ASN119, ASN142, HIE164, MET165, ASP187, ARG188 and GLN189 of SARS-CoV-2 main
protease play a crucial role in binding with ligands. The <italic>in
silico</italic> ADMET properties of the molecules are within the recommended values. The
binding free energy was calculated using PRIME MM-GB/SA studies. From the ligands
<bold>A38</bold>, <bold>A13</bold>, <bold>A23</bold>, <bold>A18</bold>, <bold>A7</bold>,
<bold>A48</bold> and <bold>A46</bold> with significant Glide scores may produce
significant COVID-19 activity for further development. Compound <bold>A38</bold> was
subjected to MD simulation at 100&#x02009;ns to study the dynamic behaviour of protein&#x02013;ligand
complex.</p><p>Communicated by Ramaswamy H. Sarma</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>acridine</kwd><kwd>oxazine</kwd><kwd>docking studies</kwd><kwd><italic>in silico</italic> ADMET screening</kwd><kwd>MM-GBSA</kwd><kwd>molecular dynamics simulation</kwd></kwd-group><counts><fig-count count="10"/><table-count count="1"/><page-count count="12"/><word-count count="5921"/></counts></article-meta></front><body><sec id="S0001" disp-level="1"><label>1.</label><title>Introduction</title><p>Recently, coronavirus disease 2019 (COVID-19), a life-threatening disease, spreads
throughout the world. The coronaviruses (CoVs) belong to severe acute respiratory syndrome
(SARS) and the Middle East respiratory syndrome (MERS) viruses (De Wit et&#x000a0;al., <xref rid="CIT0005" ref-type="bibr">2016</xref>; Song et&#x000a0;al., <xref rid="CIT0044" ref-type="bibr">2019</xref>), which contain single positive-stranded RNA. It was affected
first in China and quickly spread in most of the countries (Holshue et&#x000a0;al., <xref rid="CIT0013" ref-type="bibr">2020</xref>; Wang et&#x000a0;al., <xref rid="CIT0047" ref-type="bibr">2020</xref>; Zhou, Hou, et&#x000a0;al., <xref rid="CIT0049" ref-type="bibr">2020</xref>). According to the WHO data, as on third week of May 2020, more than 5
million people in the world are affected by COVID-19; out of these, more than 3.3 lakh
people are died. Many of the cases affected by COVID 19 are found to be asymptomatic (Gu
et&#x000a0;al., <xref rid="CIT0011" ref-type="bibr">2020</xref>; Holshue et&#x000a0;al., <xref rid="CIT0013" ref-type="bibr">2020</xref>; Lu et&#x000a0;al., <xref rid="CIT0034" ref-type="bibr">2020</xref>; To et&#x000a0;al., <xref rid="CIT0045" ref-type="bibr">2020</xref>), it is worthy of
consideration, the detail current evidence and understanding of the transmission of
SARS-CoV, MERS-CoV and SARS-CoV-2 and discuss pathogen inactivation methods on CoVs is very
important (Chang et&#x000a0;al., <xref rid="CIT0004" ref-type="bibr">2020</xref>; Huang et&#x000a0;al.,
<xref rid="CIT0014" ref-type="bibr">2020</xref>; Huang &#x00026; Herrmann, <xref rid="CIT0015" ref-type="bibr">2020</xref>; Zhang et&#x000a0;al., <xref rid="CIT0048" ref-type="bibr">2020</xref>; Zhou, Yang, et&#x000a0;al., <xref rid="CIT0050" ref-type="bibr">2020</xref>).</p><p>The CoV transfers from human to human and spreads more vigorously. In this pathetic
situation, it is important to discover some novel drugs to treat COVID-19. As
COVID-19-positive cases are increased day by day more aggressively, the finding of novel
drugs for COVID-19 treatments is one of the most encouraging tasks for target-based
treatment.</p><p>As a part of our ongoing research on searching the potent biological molecules against
various diseases by <italic>in silico</italic> and wet laboratory methods
(Kalirajan et&#x000a0;al., <xref rid="CIT0027" ref-type="bibr">2011</xref>; Kalirajan, Kulshrestha,
et&#x000a0;al., <xref rid="CIT0021" ref-type="bibr">2012</xref>; Kalirajan, Mohammed Rafick, et&#x000a0;al.,
<xref rid="CIT0022" ref-type="bibr">2012</xref>; Kalirajan et&#x000a0;al., <xref rid="CIT0025" ref-type="bibr">2013</xref>; Kalirajan, Gowramma, et&#x000a0;al., <xref rid="CIT0019" ref-type="bibr">2017</xref>; Kalirajan, Sankar, et&#x000a0;al., <xref rid="CIT0028" ref-type="bibr">2017</xref>; Kalirajan, Kulshrestha, et&#x000a0;al., <xref rid="CIT0020" ref-type="bibr">2018</xref>; Kalirajan, Mohammed Rafick, et&#x000a0;al., <xref rid="CIT0023" ref-type="bibr">2018</xref>; Kalirajan, Gaurav, et&#x000a0;al., <xref rid="CIT0018" ref-type="bibr">2019</xref>;
Kalirajan, Pandiselvi, et&#x000a0;al., <xref rid="CIT0026" ref-type="bibr">2019</xref>), we have
designed and evaluated various heterocyclic compounds for their biological activities. Using
different modules (Glide, QikProp, Prime and Desmond) of Schr&#x000f6;dinger suite LLC, various
computational methods such as molecular docking, ADMET screening, binding free energy
calculations and molecular dynamics (MD) simulations were performed to find the interactions
responsible for COVID-19 inhibition. These studies will provide the requirement of key
structural features in the design of potential drug candidates.</p><p>It is evident that from the literature studies, 9-anilinoacridines have various
pharmacological activities such as anticancer (Kapuriya et&#x000a0;al., <xref rid="CIT0031" ref-type="bibr">2008</xref>; ; Wakelin et&#x000a0;al., <xref rid="CIT0046" ref-type="bibr">2003</xref>), antimicrobial (Nadaraj et&#x000a0;al., <xref rid="CIT0037" ref-type="bibr">2009</xref>), antioxidant (Dickens et&#x000a0;al., <xref rid="CIT0006" ref-type="bibr">2002</xref>), antimalarial (Anderson et&#x000a0;al., <xref rid="CIT0001" ref-type="bibr">2006</xref>), analgesic (Sondhi et&#x000a0;al., <xref rid="CIT0043" ref-type="bibr">2002</xref>),
antileishmanial (Giorgio et&#x000a0;al., <xref rid="CIT0008" ref-type="bibr">2007</xref>),
antinociceptive (Llama et&#x000a0;al., <xref rid="CIT0033" ref-type="bibr">1989</xref>), acetyl
cholinesterase inhibitors (Recanatini et&#x000a0;al., <xref rid="CIT0041" ref-type="bibr">2000</xref>), antiherpes (Goodell et&#x000a0;al., <xref rid="CIT0009" ref-type="bibr">2006</xref>) and so forth. Amsacrine that is 9-anilinoacridine derivative was a primary
DNA-intercalating agent which is more significant and the chromophore intercalates with DNA
base pairs (Rastogi et&#x000a0;al., <xref rid="CIT0040" ref-type="bibr">2002</xref>). Similarly,
oxazine derivatives were also reported for various biological activities (Kalirajan et&#x000a0;al.,
<xref rid="CIT0029" ref-type="bibr">2009</xref>; Kalirajan, Muralidharan, et&#x000a0;al., <xref rid="CIT0024" ref-type="bibr">2012</xref>) such as antimicrobial, anti-cancer, and
larvicidal. As a part of our ongoing research work, upon looking for various biological
activities, we have designed 9-anilinoacridine analogues bearing the oxazine build-up by
docking studies with Schrodinger suit-2019-4. The recently designed 9-anilinoacridines
showed significant hindrance with COVID-19.</p></sec><sec id="S0002" disp-level="1"><label>2.</label><title>Materials and methods</title><sec id="S0002-S2001" disp-level="2"><label>2.1.</label><title>Molecular docking studies</title><p>The 3D crystal structure of COVID-19 protein called SARS-CoV-2 main protease receptor
co-crystallized with 6-(ethylamino) pyridine-3-carbonitrile (PDB ID: 5R82, Resolution:
1.31&#x02009;&#x000c5;) was retrieved from the protein data bank. The protein was prepared using protein
preparation wizard of epic module (Sastry et&#x000a0;al., <xref rid="CIT0042" ref-type="bibr">2013</xref>) of Schr&#x000f6;dinger suite 2019. The protein structure is a monomer, which was
prepared by removing similar binding sites, unnecessary water molecules and also refining
bond orders. Missing chain atoms are added by using the prime module of Schr&#x000f6;dinger suite
2019. Protein minimization was performed using optimized potentials for liquid
simulations-3 (OPLS-3) molecular force field with root mean square difference (RMSD) of
crystallographic heavy atoms kept at 0.3&#x02009;&#x000c5;. A grid box was generated to define the
centroid of the active site.</p><p>The designed ligands (<bold>A1&#x02013;A48</bold>) were prepared by using LigPrep module of
Schrodinger suite 2019-4. 2D structures were converted to 3D structures, as well as energy
minimization and optimized for their geometry, desalted and corrected for their chirality.
The ionization and tautomeric states were generated between pH 6.8 and 7.2 by using Epik
module. The ligands <bold>A1&#x02013;A48</bold> were minimized using OPLS-3 force field in
Schrodinger suit 2019-4 until a RMSD of 2.0&#x02009;&#x000c5; was achieved. A single low energy ring
confirmation per ligand was generated, and the optimized ligands were used for docking
analysis.</p><p>The compounds are prepared by LigPrep module of Schr&#x000f6;dinger suite and docked in to a
catalytic pocket of COVID-19 by using Glide module of Schr&#x000f6;dinger suite 2019 in XP (extra
precision) mode (Jacobson et&#x000a0;al., <xref rid="CIT0016" ref-type="bibr">2004</xref>). The
binding modes with best glide G scores were selected. These scores perceive positive
lipophilic, hydrogen-bonding and metal&#x02013;ligand associations and punish steric conflicts.
The XP visualizer of Glide module was used to analyze the results of docking studies
(Friesner et&#x000a0;al., <xref rid="CIT0007" ref-type="bibr">2006</xref>). The Glide score of the
molecules was compared with the Glide score of the standard compounds ritonavir,
lopinavir, nelfinavir, hydroxychloroquine and mataquine (Barros et&#x000a0;al., <xref rid="CIT0002" ref-type="bibr">2020</xref>; Cao et&#x000a0;al., <xref rid="CIT0003" ref-type="bibr">2020</xref>) which is recommended for COVID-19. The Gide scoring capacity
is mainly dependent on docking parameters like lipophilic perseverance in which the
ligands are covered in the lipophilic pocket. The electrostatic forces and hydrogen
bonding with ligands are other parameters to increase the binding affinity. Some negative
parameters like XP penalties, rotational penalties etc. will diminish the Glide score.</p><p>The <italic>in silico</italic> ADMET properties of the proposed ligands
<bold>A1&#x02013;A48</bold> were determined by QikProp module of Schrodinger suit. The prepared
ligands were subjected to the QikProp module to determine the ADMET properties such as
molecular weight, dipole moment, number of H-bond donors and acceptors, log P values,
violence in rule of five, and oral absorption.</p><p>The atomic charges were derived using B3LYP hybrid functional combined with 6-31G basis
set in Jaguar module of Schrodinger (Govindarajan et&#x000a0;al., <xref rid="CIT0010" ref-type="bibr">2012</xref>).</p></sec><sec id="S0002-S2002" disp-level="2"><label>2.2.</label><title>Binding free energy calculation by using prime/MM-GBSA approach</title><p>The binding free energy of ligand-receptor complex and post docking energy minimization
studies were performed using prime molecular mechanics-generalized born surface area
(MM-GB/SA) of Schr&#x000f6;dinger 2019. The energy for minimized XP docked pose of ligand receptor
complex was calculated using the OPLS3 force field and generalized-born/surface area
(GB/SA) continuum VSGB 2.0 solvent model (Li et&#x000a0;al., <xref rid="CIT0032" ref-type="bibr">2011</xref>).</p></sec><sec id="S0002-S2003" disp-level="2"><label>2.3.</label><title>MD simulation</title><p>The stability of the docked <bold>A38/5R82</bold> complex was investigated by performing
a 100&#x02009;ns MD (Guo et&#x000a0;al., <xref rid="CIT0012" ref-type="bibr">2010</xref>) simulation
study. The complex in the explicit solvent system with OPLS3 force field was studied using
Desmond module of Schr&#x000f6;dinger 2019-4. The molecular system was solvated with
crystallographic water (TIP3P) molecules (Jorgensen et&#x000a0;al., <xref rid="CIT0017" ref-type="bibr">1983</xref>) under orthorhombic periodic boundary conditions for 10&#x02009;&#x000c5;
buffer region. The overlapping water molecules are deleted, and the system was neutralized
by adding Na<sup>+</sup> as counter ions. The total system consists of 39,270 atoms and
11,507 water molecules. An ensemble (NPT) of Nose-Hoover thermostat (Martyna et&#x000a0;al., <xref rid="CIT0035" ref-type="bibr">1992</xref>, <xref rid="CIT0036" ref-type="bibr">1994</xref>) and barostat was applied to maintain the constant temperature (300&#x02009;K) and
pressure (1&#x02009;bar) of the systems, respectively. A hybrid energy minimization algorithm with
1000 steps of steepest descent followed by conjugate gradient algorithms was utilized.
Another algorithm, limited memory Broyden-Fletcher-Goldfarb-Shanno (LBFGS) algorithm with
convergence threshold gradient of 1&#x02009;kcal/mol/&#x000c5; was also employed for energy minimization.
A Smooth Particle Mesh Ewald method for calculating long range electrostatic interactions
with a cut-off radius of 9&#x02009;&#x000c5; for short range van der Waals and Coulomb interactions was
used. Multiple time step RESPA integration (reference system propagator algorithms) was
used in the dynamics study for bonded, near and far-bonded interactions with 2, 2 and 6
fs, respectively. The data were collected for every 100&#x02009;ps, and the obtained trajectory
was analyzed with Maestro graphical interphase.</p></sec></sec><sec id="S0003" disp-level="1"><label>3.</label><title>Results and discussion</title><p>The results are summarized in <xref rid="t0001" ref-type="table">Tables 1&#x02013;3</xref> and
<xref ref-type="fig" rid="F0001 F0002 F0003 F0004 F0005 F0006">Figures 1&#x02013;6</xref>. The
results revealed that the COVID-19 inhibitory property of the compounds <bold>A1&#x02013;A48</bold>
greatly depended on the chemical nature of the substituents. The chemical structures of
oxazine substituted 9-anilinoacridines are given in <xref ref-type="fig" rid="F0001">Figure
1</xref>.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Structures of compounds <bold>A1</bold>&#x02013;<bold>A48</bold>.</p></caption><graphic content-type="black-white" xlink:href="TBSD_A_1798285_F0001_B"/></fig><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>(a) Ligand Interaction of compound <bold>A38</bold> with COVID-19 (5R82). (b). Ligand
Interaction of compound <bold>A13</bold> with COVID-19 (5R82). (c) Ligand Interaction of
compound <bold>A23</bold> with COVID-19 (5R82). (d) Ligand Interaction of compound
<bold>A18</bold> with COVID-19 (5R82). (e) Ligand Interaction of compound
<bold>A7</bold> with COVID-19 (5R82). (f) Ligand Interaction of compound
<bold>A48</bold> with COVID-19 (5R82). (g) Ligand Interaction of compound
<bold>A46</bold> with COVID-19 (5R82). (h) Ligand Interaction of compound
<bold>A32</bold> with COVID-19 (5R82).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0002_C"/></fig><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Hydrogen bonding interaction of compound <bold>A13</bold> with COVID-19 (5R82).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0003_C"/></fig><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Hydrophilic/lipophilic map of compound <bold>A23</bold> with COVID-19 (5R82).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0004_C"/></fig><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>RMSD (&#x000c5;) of simulated protein 5R82.<italic>pdb</italic> in complex with
inhibitor <bold>A38</bold> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0005_C"/></fig><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>RMSF of simulated protein 5R82.<italic>pdb</italic> in complex with
inhibitor <bold>A38</bold> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0006_C"/></fig><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Docking studies for oxazine substituted 9-anilinoacridines <bold>A1&#x02013;A48</bold> with
COVID-19 (5R82).</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Cpd</th><th align="center">Glide score</th><th align="center">Lipophilic EvdW</th><th align="center">H Bond</th><th align="center">XP Electro</th><th align="center">Low MW</th><th align="center">XP Penalties</th><th align="center">Rot Penal</th></tr></thead><tbody valign="top"><tr><td align="left">A38</td><td align="char" char=".">&#x02212;7.829</td><td align="char" char=".">&#x02212;5.174</td><td align="center">&#x02212;1.081</td><td align="char" char=".">&#x02212;1.98</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.146</td></tr><tr><td align="left">A13</td><td align="char" char=".">&#x02212;6.78</td><td align="char" char=".">&#x02212;5.77</td><td align="center">&#x02212;1.48</td><td align="char" char=".">&#x02212;0.57</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A23</td><td align="char" char=".">&#x02212;6.65</td><td align="char" char=".">&#x02212;6.14</td><td align="center">&#x02212;0.61</td><td align="char" char=".">&#x02212;0.29</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.14</td></tr><tr><td align="left">A18</td><td align="char" char=".">&#x02212;6.37</td><td align="char" char=".">&#x02212;5.75</td><td align="center">&#x02212;1</td><td align="char" char=".">&#x02212;0.36</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.15</td></tr><tr><td align="left">A7</td><td align="char" char=".">&#x02212;6.12</td><td align="char" char=".">&#x02212;5.83</td><td align="center">&#x02212;1.04</td><td align="char" char=".">&#x02212;0.41</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A48</td><td align="char" char=".">&#x02212;5.991</td><td align="char" char=".">&#x02212;5.129</td><td align="center">&#x02212;0.882</td><td align="char" char=".">&#x02212;0.195</td><td align="center">&#x02212;0.138</td><td align="center">0</td><td align="char" char=".">0.202</td></tr><tr><td align="left">A46</td><td align="char" char=".">&#x02212;5.978</td><td align="char" char=".">&#x02212;5.145</td><td align="center">&#x02212;1.007</td><td align="char" char=".">&#x02212;0.248</td><td align="center">&#x02212;0.232</td><td align="center">0</td><td align="char" char=".">0.172</td></tr><tr><td align="left">A32</td><td align="char" char=".">&#x02212;5.805</td><td align="char" char=".">&#x02212;5.499</td><td align="center">&#x02212;1.218</td><td align="char" char=".">&#x02212;0.289</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.164</td></tr><tr><td align="left">A20</td><td align="char" char=".">&#x02212;5.80</td><td align="char" char=".">&#x02212;5.27</td><td align="center">&#x02212;1.28</td><td align="char" char=".">&#x02212;0.35</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.12</td></tr><tr><td align="left">A1</td><td align="char" char=".">&#x02212;5.79</td><td align="char" char=".">&#x02212;5.77</td><td align="center">&#x02212;0.1</td><td align="char" char=".">&#x02212;0.11</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.13</td></tr><tr><td align="left">A47</td><td align="char" char=".">&#x02212;5.784</td><td align="char" char=".">&#x02212;5.096</td><td align="center">&#x02212;0.454</td><td align="char" char=".">&#x02212;0.239</td><td align="center">&#x02212;0.185</td><td align="center">0</td><td align="char" char=".">0.161</td></tr><tr><td align="left">A36</td><td align="char" char=".">&#x02212;5.478</td><td align="char" char=".">&#x02212;5.628</td><td align="center">&#x02212;0.649</td><td align="char" char=".">&#x02212;0.398</td><td align="center">&#x02212;0.005</td><td align="center">1</td><td align="char" char=".">0.171</td></tr><tr><td align="left">A5</td><td align="char" char=".">&#x02212;5.34</td><td align="char" char=".">&#x02212;4.85</td><td align="center">&#x02212;0.89</td><td align="char" char=".">&#x02212;0.31</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.17</td></tr><tr><td align="left">A12</td><td align="char" char=".">&#x02212;5.33</td><td align="char" char=".">&#x02212;5.02</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.5</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.15</td></tr><tr><td align="left">A19</td><td align="char" char=".">&#x02212;5.22</td><td align="char" char=".">&#x02212;5.24</td><td align="center">&#x02212;0.53</td><td align="char" char=".">&#x02212;0.04</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.15</td></tr><tr><td align="left">A25</td><td align="char" char=".">&#x02212;5.15</td><td align="char" char=".">&#x02212;5.33</td><td align="center">&#x02212;0.64</td><td align="char" char=".">&#x02212;0.29</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.14</td></tr><tr><td align="left">A11</td><td align="char" char=".">&#x02212;5.05</td><td align="char" char=".">&#x02212;5.36</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.32</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A45</td><td align="char" char=".">&#x02212;4.99</td><td align="char" char=".">&#x02212;5.261</td><td align="center">&#x02212;0.53</td><td align="char" char=".">&#x02212;0.176</td><td align="center">&#x02212;0.022</td><td align="center">0</td><td align="char" char=".">0.174</td></tr><tr><td align="left">A8</td><td align="char" char=".">&#x02212;4.82</td><td align="char" char=".">&#x02212;5.42</td><td align="center">&#x02212;0.35</td><td align="char" char=".">&#x02212;0.05</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A35</td><td align="char" char=".">&#x02212;4.80</td><td align="char" char=".">&#x02212;5.316</td><td align="center">&#x02212;0.171</td><td align="char" char=".">&#x02212;0.132</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.147</td></tr><tr><td align="left">A9</td><td align="char" char=".">&#x02212;4.72</td><td align="char" char=".">&#x02212;5.46</td><td align="center">&#x02212;0.21</td><td align="char" char=".">&#x02212;0.05</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A22</td><td align="char" char=".">&#x02212;4.56</td><td align="char" char=".">&#x02212;5.38</td><td align="center">&#x02212;0.04</td><td align="char" char=".">&#x02212;0.06</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.12</td></tr><tr><td align="left">A40</td><td align="char" char=".">&#x02212;4.50</td><td align="char" char=".">&#x02212;5.217</td><td align="center">&#x02212;0.036</td><td align="char" char=".">&#x02212;0.093</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.134</td></tr><tr><td align="left">A30</td><td align="char" char=".">&#x02212;4.48</td><td align="char" char=".">&#x02212;5.42</td><td align="center">&#x02212;0.082</td><td align="char" char=".">&#x02212;0.065</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.153</td></tr><tr><td align="left">A31</td><td align="char" char=".">&#x02212;4.44</td><td align="char" char=".">&#x02212;5.683</td><td align="center">&#x02212;0.83</td><td align="char" char=".">&#x02212;0.292</td><td align="center">0</td><td align="center">1</td><td align="char" char=".">0.153</td></tr><tr><td align="left">A2</td><td align="char" char=".">&#x02212;4.40</td><td align="char" char=".">&#x02212;5.38</td><td align="center">&#x02212;0.08</td><td align="char" char=".">&#x02212;0.04</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.13</td></tr><tr><td align="left">A16</td><td align="char" char=".">&#x02212;4.38</td><td align="char" char=".">&#x02212;5.24</td><td align="center">&#x02212;0.08</td><td align="char" char=".">0.01</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.18</td></tr><tr><td align="left">A17</td><td align="char" char=".">&#x02212;4.34</td><td align="char" char=".">&#x02212;5.14</td><td align="center">&#x02212;0.19</td><td align="char" char=".">&#x02212;0.06</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.13</td></tr><tr><td align="left">A34</td><td align="char" char=".">&#x02212;4.321</td><td align="char" char=".">&#x02212;5.231</td><td align="center">0</td><td align="char" char=".">&#x02212;0.039</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.147</td></tr><tr><td align="left">A4</td><td align="char" char=".">&#x02212;4.23</td><td align="char" char=".">&#x02212;5.22</td><td align="center">&#x02212;0.12</td><td align="char" char=".">&#x02212;0.05</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.17</td></tr><tr><td align="left">A21</td><td align="char" char=".">&#x02212;4.22</td><td align="char" char=".">&#x02212;5.06</td><td align="center">0</td><td align="char" char=".">&#x02212;0.08</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.12</td></tr><tr><td align="left">A15</td><td align="char" char=".">&#x02212;4.22</td><td align="char" char=".">&#x02212;5.32</td><td align="center">0</td><td align="char" char=".">0.01</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.18</td></tr><tr><td align="left">A29</td><td align="char" char=".">&#x02212;4.202</td><td align="char" char=".">&#x02212;5.202</td><td align="center">0</td><td align="char" char=".">&#x02212;0.063</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.153</td></tr><tr><td align="left">A6</td><td align="char" char=".">&#x02212;4.16</td><td align="char" char=".">&#x02212;5.33</td><td align="center">&#x02212;0.04</td><td align="char" char=".">&#x02212;0.01</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.17</td></tr><tr><td align="left">A24</td><td align="char" char=".">&#x02212;4.04</td><td align="char" char=".">&#x02212;5.31</td><td align="center">&#x02212;0.55</td><td align="char" char=".">&#x02212;0.31</td><td align="center">0</td><td align="center">1</td><td align="char" char=".">0.13</td></tr><tr><td align="left">A37</td><td align="char" char=".">&#x02212;3.96</td><td align="char" char=".">&#x02212;5.211</td><td align="center">&#x02212;0.223</td><td align="char" char=".">&#x02212;0.285</td><td align="center">&#x02212;0.058</td><td align="center">1</td><td align="char" char=".">0.182</td></tr><tr><td align="left">A10</td><td align="char" char=".">&#x02212;3.89</td><td align="char" char=".">&#x02212;4.92</td><td align="center">0</td><td align="char" char=".">0</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A3</td><td align="char" char=".">&#x02212;3.86</td><td align="char" char=".">&#x02212;4.56</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.31</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.13</td></tr><tr><td align="left">A14</td><td align="char" char=".">&#x02212;3.82</td><td align="char" char=".">&#x02212;3.94</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.45</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.16</td></tr><tr><td align="left">A39</td><td align="char" char=".">&#x02212;3.80</td><td align="char" char=".">&#x02212;5.169</td><td align="center">&#x02212;0.024</td><td align="char" char=".">&#x02212;0.065</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.179</td></tr><tr><td align="left">A26</td><td align="char" char=".">&#x02212;3.07</td><td align="char" char=".">&#x02212;2.29</td><td align="center">&#x02212;1.35</td><td align="char" char=".">&#x02212;0.16</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.12</td></tr><tr><td align="left">A44</td><td align="char" char=".">&#x02212;3.04</td><td align="char" char=".">&#x02212;5.171</td><td align="center">&#x02212;0.072</td><td align="char" char=".">&#x02212;0.017</td><td align="center">&#x02212;0.022</td><td align="center">0</td><td align="char" char=".">0.174</td></tr><tr><td align="left">A33</td><td align="char" char=".">&#x02212;2.98</td><td align="char" char=".">&#x02212;4.977</td><td align="center">0</td><td align="char" char=".">&#x02212;0.068</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.164</td></tr><tr><td align="left">A27</td><td align="char" char=".">&#x02212;2.92</td><td align="char" char=".">&#x02212;4.943</td><td align="center">0</td><td align="char" char=".">0.044</td><td align="center">&#x02212;0.025</td><td align="center">0</td><td align="char" char=".">0.175</td></tr><tr><td align="left">A43</td><td align="char" char=".">&#x02212;2.86</td><td align="char" char=".">&#x02212;5.088</td><td align="center">&#x02212;1.048</td><td align="char" char=".">0.039</td><td align="center">&#x02212;0.022</td><td align="center">1</td><td align="char" char=".">0.174</td></tr><tr><td align="left">A28</td><td align="char" char=".">&#x02212;2.67</td><td align="char" char=".">&#x02212;4.414</td><td align="center">0</td><td align="char" char=".">&#x02212;0.133</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.155</td></tr><tr><td align="left">A41</td><td align="char" char=".">&#x02212;2.58</td><td align="char" char=".">&#x02212;3.308</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.278</td><td align="center">0</td><td align="center">1</td><td align="char" char=".">0.139</td></tr><tr><td align="left">A42</td><td align="char" char=".">&#x02212;2.23</td><td align="char" char=".">&#x02212;3.137</td><td align="center">0</td><td align="char" char=".">&#x02212;0.14</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.139</td></tr><tr><td align="left">Hydroxychloroquine (Std)</td><td align="char" char=".">&#x02212;5.47</td><td align="char" char=".">&#x02212;3.15</td><td align="center">&#x02212;1.75</td><td align="char" char=".">&#x02212;0.69</td><td align="center">&#x02212;0.38</td><td align="center">0.5</td><td align="char" char=".">0</td></tr><tr><td align="left">Ritonavir (Std)</td><td align="char" char=".">&#x02212;7.48</td><td align="char" char=".">&#x02212;6.57</td><td align="center">&#x02212;1.7</td><td align="char" char=".">&#x02212;0.46</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.22</td></tr><tr><td align="left">Lopinavir (Std)</td><td align="char" char=".">&#x02212;6.94</td><td align="char" char=".">&#x02212;6.01</td><td align="center">&#x02212;1.12</td><td align="char" char=".">&#x02212;0.26</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.24</td></tr><tr><td align="left">Nelfinavir (Std)</td><td align="char" char=".">&#x02212;5.93</td><td align="char" char=".">&#x02212;4.86</td><td align="center">&#x02212;1.18</td><td align="char" char=".">&#x02212;0.49</td><td align="center">0</td><td align="center">0</td><td align="char" char=".">0.24</td></tr><tr><td align="left">Metaquine (Std)</td><td align="char" char=".">&#x02212;5.37</td><td align="char" char=".">&#x02212;5.3</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.38</td><td align="center">&#x02212;0.06</td><td align="center">0</td><td align="char" char=".">0.18</td></tr><tr><td align="left">6-(ethylamino)pyridine-3-carbonitrile
(Bound inhibitor)</td><td align="char" char=".">&#x02212;4.40</td><td align="char" char=".">&#x02212;2.9</td><td align="center">&#x02212;0.7</td><td align="char" char=".">&#x02212;0.19</td><td align="center">&#x02212;0.5</td><td align="center">0</td><td align="char" char=".">0.29</td></tr></tbody></table></table-wrap><sec id="S0003-S2001" disp-level="2"><label>3.1.</label><title>Molecular docking studies</title><p>The docking studies of the ligands to protein active sites were performed by an advanced
molecular docking program Glide module of Schrodinger suite 2019 Maestro-12.2 version for
determining the binding affinities of the compounds. The designed analogues were docked
towards the COVID-19 (PDB ID: 5R82) in order to ascertain their inhibitory activity. The
analogues show a best fit RMSD value of 0.2. As shown in <xref rid="t0001" ref-type="table">Table 1</xref>, it is clearly demonstrated that Compound <bold>A38</bold>
has the highest G-score (&#x02212;7.83) when compared to all the standard compounds which are
proposed for COVID-19 treatment such as ritonavir (&#x02212;7.48), lopinavir (&#x02212;6.94), nelfinavir
(&#x02212;5.93), hydroxychloroquine (&#x02212;5.47) and mataquine (&#x02212;5.37). Compounds <bold>A38</bold>,
<bold>A13</bold>, <bold>A23</bold>, <bold>A18</bold>, <bold>A7</bold>, <bold>A48</bold>,
<bold>A46</bold>, <bold>A32</bold>, <bold>A20</bold>, <bold>A1</bold>, <bold>A47</bold>
and <bold>A36</bold> are significantly active against COVID-19 with Glide score more than
&#x02212;5.5 when compared to currently used drug hydroxychloroquine (&#x02212;5.47) and mataquine
(&#x02212;5.37). The above compounds have good affinity to the receptor due to more lipophilic
character and hydrogen bonding.</p><p>The docking results of the compounds exhibited similar mode of interactions with COVID-19
and the binding pocket of the residues between GLN19 and GLN189. The results are
summarized in <xref rid="t0001" ref-type="table">Table 1</xref>. Almost all Compounds
<bold>A1&#x02013;A48</bold> with COVID-19 (PDB ID: 5R82) are docked in the same binding pocket.
From <xref ref-type="fig" rid="F0002">Figure 2a</xref>, the amino acid residues GLN19,
THR24, THR25, THR26, SER46, HIE41, ASN142, HIE164 and GLN189 are making polar region and
the amino acids LEU27, MET49 and MET165 are making hydrophobic interaction with the
ligand. The hydroxyl group of the phenyl ring is interacted by hydrogen bonding with ASN
119. The Glide scores are mainly increased due to the lipophilic evidence of the aromatic
moieties. The 2D-ligand interaction diagram of compounds <bold>A38</bold>,
<bold>A13</bold>, <bold>A23</bold>, <bold>A18</bold>, <bold>A7</bold>, <bold>A48</bold>,
<bold>A46</bold> and <bold>A32</bold> with COVID-19 (PDB ID: 5R82) are given in <xref ref-type="fig" rid="F0002">Figure 2(a&#x02013;h)</xref>.</p><p>From the obtained binding modes, it was illustrated that the ligands formed hydrophobic,
hydrogen bonding and other interactions with different residues GLN19 to GLN189
surrounding the active pocket. Ligand A13 exhibited hydrogen bonding interaction with
ASN142 (H-bond length: 3.06&#x02009;&#x000c5;) and ASN119 (H-bond length: 1.79&#x02009;&#x000c5;) residues and these are
shown in <xref ref-type="fig" rid="F0003">Figure 3</xref>. The presence of aromatic
features and different heterocyclic rings majorly contributed towards lipophilic factors
(<xref ref-type="fig" rid="F0004">Figure 4</xref>).</p><p>The ADMET properties for compounds <bold>A1&#x02013;A48</bold> can be investigated by the <italic>in silico</italic> method by using QikProp module of Schr&#x000f6;dinger suite
2019-4. The molecular weight of the compounds is between 380 and 544&#x02009;g mol<sup>&#x02212;1</sup>.
The dipole moment of the compounds is between 1 and 5.7. The estimated number of hydrogen
bond donors of the compounds is in the range of 3&#x02013;4. The estimated number of hydrogen bond
acceptors of the compounds is in the range of 4.5&#x02013;6.75. The number of likely metabolites
of the compounds is in the range of 2&#x02013;6. The number of violations of Lipinski&#x02019;s rule of
five is 0&#x02013;2. The percentage of human oral absorption for the compounds is between 70% and
100%; Therefore, almost all the ADMET properties of the compounds are within the
recommended values. The results of the ADMET properties for compounds <bold>A1&#x02013;A48</bold>
are shown in Table S1 (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07391102.2020.1798285">supplementary
material</ext-link>).</p><p>The atomic charges were derived using B3LYP hybrid functional combined with 6-31G basis
set in Jaguar module of Schrodinger. The HOMO, LUMO and molecular surface property (ESP
mean) values are illustrated in Table S3 (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07391102.2020.1798285">supplementary
material</ext-link>).</p></sec><sec id="S0003-S2002" disp-level="2"><label>3.2.</label><title>Binding free energy calculation by using prime/MM-GBSA approach</title><p>Molecular docking was additionally assessed with MM-GBSA free restricting vitality, which
is identified with the post scoring approach for COVID-19 (PDB ID: 5R82) target and the
values are shown in <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07391102.2020.1798285">Supplementary Table
S2</ext-link> (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/07391102.2020.1798285">supplementary
material</ext-link>). Prime MMGBSA DG bind, the binding free energy, is calculated with
the equation: <disp-formula id="M0001"><alternatives><graphic xlink:href="TBSD_A_1798285_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d1e1571"><mml:mrow><mml:mo>&#x00394;</mml:mo><mml:mi mathvariant="normal">G</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>bind</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mo>_</mml:mo><mml:mtext>complex</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>minimized</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi mathvariant="normal">E</mml:mi><mml:mo>_</mml:mo><mml:mtext>ligand</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>minimized</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mi mathvariant="normal">E</mml:mi><mml:mo>_</mml:mo><mml:mtext>receptor</mml:mtext><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mtext>minimized</mml:mtext></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></disp-formula>
</p><p>From the results of MM-GB/SA studies, the &#x00394;<italic>G</italic> bind values
were observed in the range of &#x02212;26.01 (cpdA35) to &#x02212;63.24&#x02009;kcal/mol (cpdA14) for
significantly active compounds and also dGvdw values, dG lipophilic values and the
energies are positively contributing towards total binding energy. The stability of
docking complex will be predicted by MMGBSA scoring function. The Glide score and MM-GBSA
free energy are obtained by the docking of ligands into the coupling pocket, which are
more stable.</p></sec><sec id="S0003-S2003" disp-level="2"><label>3.3.</label><title>MD simulation</title><p>A 100-ns molecular dynamic simulation was performed to understand the molecular insights
involved in binding of <bold>A38</bold> in the active pocket of 5R82. From the obtained
trajectory analysis, the RMSD of protein C&#x003b1;, backbone and heavy atoms was observed in the
range of 1.25&#x02013;2.1&#x02009;&#x000c5; and 1.45&#x02013;2.45&#x02009;&#x000c5;, respectively (<xref ref-type="fig" rid="F0005">Figure
5</xref>). The C&#x003b1; atoms fluctuated in the range of 1.25&#x02013;2.1&#x02009;&#x000c5; and finally stabilized
after 80&#x02009;ns of simulation with a RMSD value of 1.5&#x02009;&#x000c5;. Higher fluctuations (up to 2.1&#x02009;&#x000c5;) in
RMSD were observed at 39&#x02013;42&#x02009;ns and 79&#x02009;ns. Over the course of simulation, stable
hydrophobic interactions were observed with His41 and Met165. The flexibility of residues
on ligand binding is analyzed using metrics of root mean square fluctuations (RMSFs)
(<xref ref-type="fig" rid="F0006">Figure 6</xref>). High flexibility was observed with
RMSF of Ser1 (C&#x003b1;: 4.67&#x02009;&#x000c5;; backbone: 4.77&#x02009;&#x000c5;) and Val303 (C&#x003b1;: 5.95&#x02009;&#x000c5;; backbone: 6.02&#x02009;&#x000c5;),
whereas low RMSF was reported for residues Leu205 (C&#x003b1;: 0.37&#x02009;&#x000c5;; backbone: 0.38&#x02009;&#x000c5;) and
Thr175 (C&#x003b1;: 0.43&#x02009;&#x000c5;; backbone: 0.46&#x02009;&#x000c5;). The stability of ligand with respect to protein was
indicated using ligand RMSD where a moderate fluctuation of 1.72&#x02009;&#x000c5; was observed (<xref ref-type="fig" rid="F0006">Figure 6</xref>).</p><p>A total of 27 ligand contacts (<xref ref-type="fig" rid="F0007">Figure 7</xref>) were
formed with amino acids of protein, from Gln19 to Met49, Asn119, Phe140 to Pro168 and
Phe181 to Gln192. From <xref ref-type="fig" rid="F0008">Figure 8</xref>, it was stated
that the ligand is stabilized by forming majority of hydrophobic interactions (5%&#x02013;90% of
simulation time) with residues His41, Met49, Cys145, Met165, Leu167, Pro168 and Phe181. It
also formed hydrogen bonds with Gly19, Asn28, His41, Asn119, Asn142, Gly143, Ser144 and
Gln189 over the course of 10%&#x02013;65% of simulation trajectory. The timeline representation of
protein-ligand contacts is outlined in <xref ref-type="fig" rid="F0008">Figure
8</xref>.</p><fig id="F0007" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Interaction fraction of 5R82.<italic>pdb</italic> complexed with
<bold>A38</bold> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0007_C"/></fig><fig id="F0008" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Time line representation showing different contacts formed by <bold>A38</bold> in
complex with 5R82.<italic>pdb</italic> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0008_C"/></fig><p>The 2D-trajectory interaction diagram (<xref ref-type="fig" rid="F0009">Figure 9</xref>)
depicts that the hydrogen bond formed by the docking pose with Asn119 is preserved in the
MD trajectory pose. The methoxy group in compound A38 donated one hydrogen bond to Asn119
with 24%, the nitrogen of acridine ring accepted one hydrogen bond with Arg188 and Ser144
through water molecule with 21% and 51% of total simulation time, respectively. The
nitrogen of the oxazine ring accepted one hydrogen bond from Gly143 and the amino group
accepted hydrogen bonds from Gly143 and Ser144 with 58% and 51%, respectively, of total
simulation time. The pi-pi stacking of acridine with His41 was 67%. The RMSF (<xref ref-type="fig" rid="F0010">Figure 10</xref>) of ligand with respect to initial frame was
observed in the range of 0.5&#x02013;1.48&#x02009;&#x000c5;. Other ligand properties (<xref ref-type="fig" rid="F0010">Figure 10</xref>) such as radius of gyration, molecular surface area,
solvent accessible surface area and polar surface area of ligands were observed in the
range of 5.85&#x02013;6.07&#x02009;&#x000c5;, 444.94&#x02013;453.42 &#x000c5;<sup>2</sup>, 228.75&#x02013;453.338.82 &#x000c5;<sup>2</sup> and
149.94&#x02013;164.73 &#x000c5;<sup>2</sup>, respectively.</p><fig id="F0009" orientation="portrait" position="float"><label>Figure 9.</label><caption><p>2D interaction diagram of <bold>A38</bold> in complex with 5R82.<italic>pdb</italic> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0009_C"/></fig><fig id="F0010" orientation="portrait" position="float"><label>Figure 10.</label><caption><p>Ligand properties of <bold>A38</bold> in complex with 5R82.<italic>pdb</italic> during 100&#x02009;ns MD simulation.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1798285_F0010_C"/></fig></sec></sec><sec id="S0004" disp-level="1"><label>4.</label><title>Conclusion</title><p>In conclusion, from the oxazine-substituted 9-anilinoacridines <bold>A1&#x02013;A48</bold>, many
compounds have significant binding affinity with SARS CoV-2 main protease. Molecular docking
and binding free energy calculation studies were performed to find the possible binding
modes of ligands and the influence of favorable and non-favourable interactions within the
active pocket of COVID-19 protein. MD simulation for the highly active inhibitor
<bold>A38</bold> in complex with protein 5R82 revealed that the stabilization of ligand
was achieved due to the formation of uninterrupted hydrophobic interactions. The results
demonstrated for further modifications in pharmacophoric features may help in improvement of
inhibitory activity. The <italic>in silico</italic> structuring strategy
embraced in the present investigation helped for recognizing some lead molecules and
furthermore may somewhat clarify their useful impact for further determinations like <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic> assessments. The
results from the <italic>in silico</italic> study exhibited that compounds
<bold>A38</bold>, <bold>A13</bold>, <bold>A23</bold>, <bold>A18</bold> and <bold>A7</bold>
may be significantly active against COVID-19 with remedial possibilities and are probably
going to be helpful after further refinement.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM7947"><caption><title>Supplementary_materials...docx</title></caption><media xlink:href="TBSD_A_1798285_SM7947.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors express their sincere gratitude to JSS Academy of Higher Education &#x00026;
Research, Mysuru. The authors also thank the principal Dr. S. P. Dhanabal, JSS College of
Pharmacy, Ooty, for the technical support.</p></ack><sec id="S0005" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>M.
O.</given-names></name>, <name name-style="western"><surname>Sherrill</surname><given-names>J.</given-names></name>,
<name name-style="western"><surname>Madrid</surname><given-names>P.
B.</given-names></name>, <name name-style="western"><surname>Liou</surname><given-names>A. P.</given-names></name>,
<name name-style="western"><surname>Weisman</surname><given-names>J.
L.</given-names></name>, <name name-style="western"><surname>DeRisi</surname><given-names>J. L.</given-names></name>, &#x00026;
<name name-style="western"><surname>Guy</surname><given-names>R.
K.</given-names></name></person-group> (<year>2006</year>).
<article-title>Parallel synthesis of 9-aminoacridines and their evaluation against
chloroquine-resistant Plasmodium falciparum</article-title>. <source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source>, (<issue>2</issue>),
<fpage>334</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2005.08.017</pub-id><pub-id pub-id-type="pmid">16216519</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barros</surname><given-names>R.
O.</given-names></name>, <name name-style="western"><surname>Junior</surname><given-names>F. L. C. C.</given-names></name>,
<name name-style="western"><surname>Pereira</surname><given-names>W.
S.</given-names></name>, <name name-style="western"><surname>Oliveira</surname><given-names>N. M. N.</given-names></name>,
&#x00026; <name name-style="western"><surname>Ramos</surname><given-names>R.</given-names></name></person-group> (<year>2020</year>).
<article-title>Interaction of drugs candidates with various SARS-CoV-2 receptors: An in
silico study to combat COVID-19</article-title>. <source><italic toggle="yes">ChemRxiv</italic></source>. Preprint. <pub-id pub-id-type="doi">10.26434/chemrxiv.12100968.v4</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Ruan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, &#x02026; <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name></person-group>
(<year>2020</year>). <article-title>A trial of lopinavir-ritonavir in adults
hospitalized with severe Covid-19</article-title>. <source><italic toggle="yes">The New
England Journal of Medicine</italic></source>, (<issue>19</issue>), <fpage>1787</fpage>&#x02013;<lpage>1799</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id><pub-id pub-id-type="pmid">32187464</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name>, &#x00026;
<name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name></person-group> (<year>2020</year>).
<article-title>Coronavirus disease 2019: Coronaviruses and blood safety</article-title>.
<source><italic toggle="yes">Transfusion Medicine Reviews</italic></source>,
(<issue>2</issue>),
<fpage>75</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.tmrv.2020.02.003</pub-id><pub-id pub-id-type="pmid">32107119</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Wit</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Van Doremalen</surname><given-names>N.</given-names></name>,
<name name-style="western"><surname>Falzarano</surname><given-names>D.</given-names></name>, &#x00026; <name name-style="western"><surname>Munster</surname><given-names>V.
J.</given-names></name></person-group> (<year>2016</year>). <article-title>SARS
and MERS: Recent insights into emerging coronaviruses</article-title>. <source><italic toggle="yes">Nature Reviews. Microbiology</italic></source>, (<issue>8</issue>),
<fpage>523</fpage>&#x02013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2016.81</pub-id><pub-id pub-id-type="pmid">27344959</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dickens</surname><given-names>B.
F.</given-names></name>, <name name-style="western"><surname>Weglicki</surname><given-names>W. B.</given-names></name>,
<name name-style="western"><surname>Boehme</surname><given-names>P.
A.</given-names></name>, &#x00026; <name name-style="western"><surname>Mak</surname><given-names>I.
T.</given-names></name></person-group> (<year>2002</year>).
<article-title>Antioxidant and lysosomotropic properties of acridine-propranolol:
Protection against oxidative endothelial cell injury</article-title>. <source><italic toggle="yes">Journal of Molecular and Cellular Cardiology</italic></source>,
(<issue>2</issue>),
<fpage>129</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001282</pub-id>
<pub-id pub-id-type="doi">10.1006/jmcc.2001.1495</pub-id><pub-id pub-id-type="pmid">11851353</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friesner</surname><given-names>R.
A.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>R. B.</given-names></name>,
<name name-style="western"><surname>Repasky</surname><given-names>M.
P.</given-names></name>, <name name-style="western"><surname>Frye</surname><given-names>L. L.</given-names></name>,
<name name-style="western"><surname>Greenwood</surname><given-names>J.
R.</given-names></name>, <name name-style="western"><surname>Halgren</surname><given-names>T. A.</given-names></name>,
<name name-style="western"><surname>Sanschagrin</surname><given-names>P.
C.</given-names></name>, &#x00026; <name name-style="western"><surname>Mainz</surname><given-names>D.
T.</given-names></name></person-group> (<year>2006</year>). <article-title>Extra
precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for
protein-ligand complexes</article-title>. <source><italic toggle="yes">Journal of
Medicinal Chemistry</italic></source>, (<issue>21</issue>), <fpage>6177</fpage>&#x02013;<lpage>6196</lpage>.
<pub-id pub-id-type="doi">10.1021/jm051256o</pub-id><pub-id pub-id-type="pmid">17034125</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giorgio</surname><given-names>C.
D.</given-names></name>, <name name-style="western"><surname>Shimi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Boyer</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Delmas</surname><given-names>F.</given-names></name>, &#x00026;
<name name-style="western"><surname>Galy</surname><given-names>J.
P.</given-names></name></person-group> (<year>2007</year>).
<article-title>Synthesis and antileishmanial activity of 6-mono-substituted and
3,6-di-substituted acridines obtained by acylation of proflavine</article-title>.
<source><italic toggle="yes">European Journal of Medicinal
Chemistry</italic></source>, (<issue>10</issue>), <fpage>1277</fpage>&#x02013;<lpage>1284</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ejmech.2007.02.010</pub-id><pub-id pub-id-type="pmid">17418916</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodell</surname><given-names>J.
R.</given-names></name>, <name name-style="western"><surname>Madhok</surname><given-names>A. A.</given-names></name>,
<name name-style="western"><surname>Hiasa</surname><given-names>H.</given-names></name>, &#x00026; <name name-style="western"><surname>Ferguson</surname><given-names>D.
M.</given-names></name></person-group> (<year>2006</year>).
<article-title>Synthesis and evaluation of acridine- and acridone-based anti-herpes
agents with topoisomerase activity</article-title>. <source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source>, (<issue>16</issue>), <fpage>5467</fpage>&#x02013;<lpage>5480</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bmc.2006.04.044</pub-id><pub-id pub-id-type="pmid">16713270</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Govindarajan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Periandy</surname><given-names>S.</given-names></name>, &#x00026;
<name name-style="western"><surname>Carthigayen</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>).
<article-title>FT-IR and FT-Raman spectra, thermo dynamical behavior, HOMO and LUMO, UV,
NLO properties, computed frequency estimation analysis and electronic structure
calculations on &#x003b1;-bromotoluene</article-title>. <source><italic toggle="yes">Spectrochimica Acta. Part A, Molecular and Biomolecular
Spectroscopy</italic></source>, ,
<fpage>411</fpage>&#x02013;<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2012.06.028</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>B.</given-names></name>, &#x00026;
<name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>).
<article-title>COVID-19: Gastrointestinal manifestations and potential fecal -oral
transmission</article-title>. <source><italic toggle="yes">Gastroenterology</italic></source>, ,
<fpage>1518</fpage>&#x02013;<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2020.02.054</pub-id><pub-id pub-id-type="pmid">32142785</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Mohanty</surname><given-names>U.</given-names></name>,
<name name-style="western"><surname>Noehre</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Sawyer</surname><given-names>T. K.</given-names></name>,
<name name-style="western"><surname>Sherman</surname><given-names>W.</given-names></name>, &#x00026; <name name-style="western"><surname>Krilov</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>).
<article-title>Probing the alpha-helical structural stability of stapled p53 peptides:
Molecular dynamics simulations and analysis</article-title>. <source><italic toggle="yes">Chemical Biology &#x00026; Drug Design</italic></source>, (<issue>4</issue>),
<fpage>348</fpage>&#x02013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1111/j.1747-0285.2010.00951.x</pub-id><pub-id pub-id-type="pmid">20331649</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holshue</surname><given-names>M.
L.</given-names></name>, <name name-style="western"><surname>DeBolt</surname><given-names>C.</given-names></name>,
<name name-style="western"><surname>Lindquist</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lofy</surname><given-names>K. H.</given-names></name>,
<name name-style="western"><surname>Wiesman</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bruce</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Spitters</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ericson</surname><given-names>K.</given-names></name>,
<name name-style="western"><surname>Wilkerson</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tural</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fox</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gerber</surname><given-names>S.
I.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lindstrom</surname><given-names>S.</given-names></name>, &#x02026; <name name-style="western"><surname>Pillai</surname><given-names>S.
K.</given-names></name></person-group> (<year>2020</year>). <article-title>First
case of 2019 novel coronavirus in the United States</article-title>. <source><italic toggle="yes">New England Journal of Medicine</italic></source>, (<issue>10</issue>),
<fpage>929</fpage>&#x02013;<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001191</pub-id><pub-id pub-id-type="pmid">32004427</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, &#x00026; <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name></person-group>
(<year>2020</year>). <article-title>Clinical features of patients infected with 2019
novel coronavirus in Wuhan, China</article-title>. <source><italic toggle="yes">Lancet</italic></source>, ,
<fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(20)30183-5</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Q.</given-names></name>, &#x00026; <name name-style="western"><surname>Herrmann</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>).
<article-title>Fast assessment of human receptor-binding capability of 2019 novel
coronavirus (2019-nCoV)</article-title>. BioRxiv 930537. <pub-id pub-id-type="doi">10.1101/2020.02.01.930537</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobson</surname><given-names>M.
P.</given-names></name>, <name name-style="western"><surname>Pincus</surname><given-names>D. L.</given-names></name>,
<name name-style="western"><surname>Rapp</surname><given-names>C.
S.</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>T. J. F.</given-names></name>,
<name name-style="western"><surname>Honig</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>D. E.</given-names></name>, &#x00026;
<name name-style="western"><surname>Friesner</surname><given-names>R.
A.</given-names></name></person-group> (<year>2004</year>). <article-title>A
hierarchical approach to all-atom protein loop prediction</article-title>.
<source><italic toggle="yes">Proteins</italic></source>, (<issue>2</issue>), <fpage>351</fpage>&#x02013;<lpage>367</lpage>.
<pub-id pub-id-type="doi">10.1002/prot.10613</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jorgensen</surname><given-names>W.
L.</given-names></name>, <name name-style="western"><surname>Chandrasekhar</surname><given-names>J.</given-names></name>,
<name name-style="western"><surname>Madura</surname><given-names>J.
D.</given-names></name>, <name name-style="western"><surname>Impey</surname><given-names>R. W.</given-names></name>, &#x00026;
<name name-style="western"><surname>Klein</surname><given-names>M.
L.</given-names></name></person-group> (<year>1983</year>).
<article-title>Comparison of simple potential functions for simulating liquid
water</article-title>. <source><italic toggle="yes">The Journal of Chemical
Physics</italic></source>, (<issue>2</issue>), <fpage>926</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1063/1.445869</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gaurav</surname><given-names>K.</given-names></name>,
<name name-style="western"><surname>Pandiselvi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>, &#x00026;
<name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>).
<article-title>Novel thiazine substituted 9-anilinoacridines: Synthesis, antitumour
activity and structure activity relationships</article-title>. <source><italic toggle="yes">Anti-Cancer Agents in Medicinal Chemistry</italic></source>,
(<issue>11</issue>),
<fpage>1350</fpage>&#x02013;<lpage>1358</lpage>. <pub-id pub-id-type="doi">10.2174/1871520619666190408134224</pub-id><pub-id pub-id-type="pmid">30961512</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>).
<article-title>Molecular docking studies and <italic>in silico</italic>
ADMET screening of some novel heterocyclic substituted 9-anilinoacridines as
topoisomerase II inhibitors</article-title>. <source><italic toggle="yes">JSM
Chemistry</italic></source>, (<issue>1</issue>),
<fpage>1039</fpage>&#x02013;<lpage>1044</lpage>.</mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kulshrestha</surname><given-names>V.</given-names></name>, &#x00026;
<name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>).
<article-title>Synthesis, characterization and evaluation for antitumour activity of
some novel oxazine substituted 9-anilinoacridines and their 3D-QSAR
studies</article-title>. <source><italic toggle="yes">Indian Journal of Pharmaceutical
Sciences</italic></source>, (<issue>5</issue>), <fpage>921</fpage>&#x02013;<lpage>929</lpage>. <pub-id pub-id-type="doi">10.4172/pharmaceutical-sciences.1000439</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kulshrestha</surname><given-names>V.</given-names></name>,
<name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>).
<article-title>Docking studies, synthesis, characterization of some novel oxazine
substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and
anticancer activities as topoisomerase II inhibitors</article-title>. <source><italic toggle="yes">European Journal of Medicinal Chemistry</italic></source>,
,
<fpage>217</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.08.025</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mohammed Rafick</surname><given-names>M. H.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>).
<article-title>Docking studies, synthesis, characterization and evaluation of their
antioxidant and cytotoxic activities of some novel isoxazole substituted
9-anilinoacridine derivatives</article-title>. <source><italic toggle="yes">The
Scientific World Journal</italic></source>, , <fpage>1</fpage>&#x02013;<lpage>6</lpage>. 2012. <pub-id pub-id-type="doi">10.1100/2012/165258,</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mohammed Rafick</surname><given-names>M. H.</given-names></name>,
<name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>).
<article-title>Green synthesis of some novel chalcone and isoxazole substituted
9-anilinoacridine derivatives and evaluation of their antimicrobial and larvicidal
activities</article-title>. <source><italic toggle="yes">Indian Journal of
Chemistry</italic></source>, ,
<fpage>583</fpage>&#x02013;<lpage>590</lpage>.</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Muralidharan</surname><given-names>V.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>,
<name name-style="western"><surname>Gomathy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name>, &#x00026;
<name name-style="western"><surname>Elango</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>).
<article-title>Synthesis of some novel pyrazole substituted 9-anilinoacridine
derivatives and evaluation for their antioxidant and cytotoxic
activities</article-title>. <source><italic toggle="yes">Journal of Heterocyclic
Chemistry</italic></source>, (<issue>4</issue>), <fpage>748</fpage>&#x02013;<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1002/jhet.848</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Muralidharan</surname><given-names>V.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>).
<article-title>Microwave assisted synthesis, characterization and evaluation for their
antimicrobial activities of some novel pyrazole substituted 9-anilino acridine
derivatives</article-title>. <source><italic toggle="yes">International Journal of
Health &#x00026; Allied Sciences</italic></source>, (<issue>2</issue>), <fpage>81</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.4103/2278-344X.115682</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pandiselvi</surname><given-names>A.</given-names></name>,
<name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>, &#x00026; <name name-style="western"><surname>Balachandran</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>).
<article-title><italic>In-silico</italic> design, ADMET screening,
MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as
HER2 inhibitors targeting breast cancer</article-title>. <source><italic toggle="yes">Current Drug Research Reviews</italic></source>, (<issue>2</issue>), <fpage>118</fpage>&#x02013;<lpage>128</lpage>.
<pub-id pub-id-type="doi">10.2174/2589977511666190912154817</pub-id><pub-id pub-id-type="pmid">31513003</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rathore</surname><given-names>L.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>,
<name name-style="western"><surname>Gomathy</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>).
<article-title>Microwave assisted synthesis of some novel pyrazole substituted
benzimidazoles and evaluation of their biological activities</article-title>.
<source><italic toggle="yes">Indian Journal of Chemistry</italic></source>,
,
<fpage>1794</fpage>&#x02013;<lpage>1801</lpage>. <pub-id pub-id-type="doi">10.1002/chin.201216123</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sankar</surname><given-names>S.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, and., &#x00026; <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>).
<article-title>Molecular docking studies and <italic>in-silico</italic>
ADMET screening of some novel oxazine substituted 9-anilinoacridines as topoisomerase II
inhibitors</article-title>. <source><italic toggle="yes">Indian Journal of
Pharmaceutical Education and Research</italic></source>, (<issue>1</issue>), <fpage>110</fpage>&#x02013;<lpage>115</lpage>.
<pub-id pub-id-type="doi">10.5530/ijper.51.1.15</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalirajan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sivakumar</surname><given-names>S. U.</given-names></name>,
<name name-style="western"><surname>Jubie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gowramma</surname><given-names>B.</given-names></name>, &#x00026;
<name name-style="western"><surname>Suresh</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>).
<article-title>Synthesis and biological evaluation of some heterocyclic derivatives of
chalcones</article-title>. <source><italic toggle="yes">International Journal of
Chemical Science</italic></source>, (<issue>1</issue>),
<fpage>27</fpage>&#x02013;<lpage>34</lpage>.</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kapuriya</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kapuriya</surname><given-names>K.</given-names></name>,
<name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>T.-C.</given-names></name>,
<name name-style="western"><surname>Kakadiya</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.-T.</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>T.-H.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.-T.</given-names></name>,
<name name-style="western"><surname>Lee</surname><given-names>T.-C.</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Naliapara</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Su</surname><given-names>T.-L.</given-names></name></person-group> (<year>2008</year>).
<article-title>Synthesis and biological activity of stable and potent antitumor agents,
aniline nitrogen mustards linked to 9-anilinoacridines via a urea
linkage</article-title>. <source><italic toggle="yes">Bioorganic &#x00026; Medicinal
Chemistry</italic></source>, (<issue>10</issue>), <fpage>5413</fpage>&#x02013;<lpage>5423</lpage>.
<pub-id pub-id-type="doi">10.1016/j.bmc.2008.04.024</pub-id><pub-id pub-id-type="pmid">18450456</pub-id></mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Abel</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name>, &#x00026; <name name-style="western"><surname>Friesner</surname><given-names>R.
A.</given-names></name></person-group> (<year>2011</year>). <article-title>The
VSGB 2.0 model: A next generation energy model for high resolution protein structure
modeling</article-title>. <source><italic toggle="yes">Proteins</italic></source>,
(<issue>10</issue>),
<fpage>2794</fpage>&#x02013;<lpage>2812</lpage>. <pub-id pub-id-type="doi">10.1002/prot.23106</pub-id><pub-id pub-id-type="pmid">21905107</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Llama</surname><given-names>E.
F.</given-names></name>, <name name-style="western"><surname>Campo</surname><given-names>C. D.</given-names></name>,
<name name-style="western"><surname>Capo</surname><given-names>M.</given-names></name>, &#x00026; <name name-style="western"><surname>Anadon</surname><given-names>M.</given-names></name></person-group> (<year>1989</year>).
<article-title>Synthesis and antinociceptive activity of 9-phenyl-oxy or 9-acyl-oxy
derivatives of xanthene, thioxanthene and acridine</article-title>. <source><italic toggle="yes">European Journal of Medicinal Chemistry</italic></source>,
(<issue>4</issue>),
<fpage>391</fpage>&#x02013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/0223-5234(89)90083-4</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, &#x00026;
<name name-style="western"><surname>Li</surname><given-names>J.</given-names></name></person-group> (<year>2020</year>).
<article-title>Genomic characterisation and epidemiology of 2019 novel coronavirus:
Implications for virus origins and receptor binding</article-title>. <source><italic toggle="yes">Lancet</italic></source>, (<issue>10224</issue>), <fpage>565</fpage>&#x02013;<lpage>574</lpage>.
<pub-id pub-id-type="doi">10.1016/S0140-6736(20)3025</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martyna</surname><given-names>G.
J.</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>M. L.</given-names></name>, &#x00026;
<name name-style="western"><surname>Tuckerman</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>).
<article-title>Nose- Hoover chains-the canonical ensemble via continuous
dynamics</article-title>. <source><italic toggle="yes">The Journal of Chemical
Physics</italic></source>, (<issue>4</issue>), <fpage>2635</fpage>&#x02013;<lpage>2643</lpage>.
<pub-id pub-id-type="doi">10.1063/1.463940</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martyna</surname><given-names>G.
J.</given-names></name>, <name name-style="western"><surname>Tobias</surname><given-names>D. J.</given-names></name>, &#x00026;
<name name-style="western"><surname>Klein</surname><given-names>M.
L.</given-names></name></person-group> (<year>1994</year>).
<article-title>Constant-pressure molecular dynamics algorithms</article-title>.
<source><italic toggle="yes">The Journal of Chemical Physics</italic></source>,
(<issue>5</issue>),
<fpage>4177</fpage>&#x02013;<lpage>4189</lpage>. <pub-id pub-id-type="doi">10.1063/1.467468</pub-id></mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nadaraj</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Selvi</surname><given-names>S. T.</given-names></name>, &#x00026;
<name name-style="western"><surname>Mohan</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>).
<article-title>Microwave-induced synthesis and anti-microbial activities of
7,10,11,12-tetrahydrobenzo[c]acridin-8(9H)-one derivatives</article-title>.
<source><italic toggle="yes">European Journal of Medicinal
Chemistry</italic></source>, (<issue>3</issue>), <fpage>976</fpage>&#x02013;<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2008.07.004</pub-id><pub-id pub-id-type="pmid">18718695</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rastogi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>J.-Y.</given-names></name>,
<name name-style="western"><surname>Pan</surname><given-names>W.-Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.-H.</given-names></name>,
<name name-style="western"><surname>Chou</surname><given-names>T.-C.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L.-T.</given-names></name>, &#x00026;
<name name-style="western"><surname>Su</surname><given-names>T.-L.</given-names></name></person-group> (<year>2002</year>).
<article-title>Antitumor AHMA linked to DNA minor groove binding agents: Synthesis and
biological evaluation</article-title>. <source><italic toggle="yes">Journal of Medicinal
Chemistry</italic></source>, (<issue>20</issue>), <fpage>4485</fpage>&#x02013;<lpage>4493</lpage>.
<pub-id pub-id-type="doi">10.1021/jm0200714</pub-id><pub-id pub-id-type="pmid">12238927</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Recanatini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cavalli</surname><given-names>A.</given-names></name>,
<name name-style="western"><surname>Belluti</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Piazzi</surname><given-names>L.</given-names></name>,
<name name-style="western"><surname>Rampa</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bisi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gobbi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Valenti</surname><given-names>P.</given-names></name>,
<name name-style="western"><surname>Andrisano</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Bartolini</surname><given-names>M.</given-names></name>, &#x00026;
<name name-style="western"><surname>Cavrini</surname><given-names>V.</given-names></name></person-group> (<year>2000</year>).
<article-title>SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase
inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of
tacrine analogues</article-title> . <source><italic toggle="yes">Journal of Medicinal
Chemistry</italic></source>, (<issue>10</issue>), <fpage>2007</fpage>&#x02013;<lpage>2018</lpage>.
<pub-id pub-id-type="doi">10.1021/jm990971t</pub-id><pub-id pub-id-type="pmid">10821713</pub-id></mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sastry</surname><given-names>G.
M.</given-names></name>, <name name-style="western"><surname>Adzhigirey</surname><given-names>M.</given-names></name>,
<name name-style="western"><surname>Day</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Annabhimoju</surname><given-names>R.</given-names></name>, &#x00026;
<name name-style="western"><surname>Sherman</surname><given-names>W.</given-names></name></person-group> (<year>2013</year>).
<article-title>Protein and ligand preparation: Parameters, protocols, and influence on
virtual screening enrichments</article-title>. <source><italic toggle="yes">Journal of
Computer-Aided Molecular Design</italic></source>, (<issue>3</issue>), <fpage>221</fpage>&#x02013;<lpage>234</lpage>.
<pub-id pub-id-type="doi">10.1007/s10822-013-9644-8</pub-id><pub-id pub-id-type="pmid">23579614</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sondhi</surname><given-names>S.
M.</given-names></name>, <name name-style="western"><surname>Johar</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nirupama</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sukla</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Raghubir</surname><given-names>R.</given-names></name>, &#x00026; <name name-style="western"><surname>Dastidar</surname><given-names>S.
G.</given-names></name></person-group> (<year>2002</year>).
<article-title>Synthesis of sulpha drug acridine derivatives and their evaluation for
anti-anflammatory, analgesic and anticancer activity</article-title>. <source><italic toggle="yes">Indian Journal of Chemistry</italic></source>, ,
<fpage>2659</fpage>&#x02013;<lpage>2666</lpage>.</mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name>, &#x00026; <name name-style="western"><surname>Qin</surname><given-names>C.</given-names></name></person-group>
(<year>2019</year>). <article-title>From SARS to MERS, thrusting coronaviruses into the
spotlight</article-title>. <source><italic toggle="yes">Viruses</italic></source>,
(<issue>1</issue>),
<fpage>59</fpage>
<pub-id pub-id-type="doi">10.3390/v11010059</pub-id></mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>To</surname><given-names>K.
K.</given-names></name>, <name name-style="western"><surname>Tsang</surname><given-names>O. T.</given-names></name>, &#x00026;
<name name-style="western"><surname>Chik-Yan Yip</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>).
<article-title>Consistent detection of 2019 novel coronavirus in saliva</article-title>.
<source><italic toggle="yes">Clinical Infectious Diseases</italic></source>. <pub-id pub-id-type="doi">10.1093/cid/ciaa149</pub-id></mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wakelin</surname><given-names>L. P.
G.</given-names></name>, <name name-style="western"><surname>Bu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Eleftheriou</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Parmar</surname><given-names>A.</given-names></name>,
<name name-style="western"><surname>Hayek</surname><given-names>C.</given-names></name>, &#x00026; <name name-style="western"><surname>Stewart</surname><given-names>B.
W.</given-names></name></person-group> (<year>2003</year>).
<article-title>Bisintercalating threading diacridines: Relationships between DNA
binding, cytotoxicity, and cell cycle arrest</article-title>. <source><italic toggle="yes">Journal of Medicinal Chemistry</italic></source>, (<issue>26</issue>),
<fpage>5790</fpage>&#x02013;<lpage>5802</lpage>. <pub-id pub-id-type="doi">10.1021/jm030253d</pub-id><pub-id pub-id-type="pmid">14667232</pub-id></mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Xiang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, &#x00026; <name name-style="western"><surname>Peng</surname><given-names>Z.</given-names></name></person-group>
(<year>2020</year>). <article-title>Clinical characteristics of 138 hospitalized
patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</article-title>.
<source><italic toggle="yes">JAMA</italic></source>, (<issue>11</issue>), <fpage>1061</fpage>
<pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id></mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>Z. J.</given-names></name>, &#x00026;
<name name-style="western"><surname>Gong</surname><given-names>H.
Y.</given-names></name></person-group> (<year>2020</year>).
<article-title>The digestive system is a potential route of 2019-nCov infection: A
bioinformatics analysis based on single-cell transcriptomes</article-title>. BioRxiv
927806. <pub-id pub-id-type="doi">10.1101/2020.01.30.927806</pub-id></mixed-citation></ref><ref id="CIT0049"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>W.</given-names></name>, &#x00026; <name name-style="western"><surname>Cheng</surname><given-names>F.</given-names></name></person-group> (<year>2020</year>).
<article-title>Network-based drug repurposing for novel coronavirus
2019-nCoV/SARS-CoV-2</article-title>. <source><italic toggle="yes">Cell
Discovery</italic></source>, ,
<fpage>14</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1038/s41421-020-0153-3</pub-id><pub-id pub-id-type="pmid">32194980</pub-id></mixed-citation></ref><ref id="CIT0050"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.-L.</given-names></name>,
<name name-style="western"><surname>Wang</surname><given-names>X.-G.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Si</surname><given-names>H.-R.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C.-L.</given-names></name>,
<name name-style="western"><surname>Chen</surname><given-names>H.-D.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Guo</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>R.-D.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>M.-Q.</given-names></name>,
<name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>X.-R.</given-names></name>,
<name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, &#x02026; <name name-style="western"><surname>Shi</surname><given-names>Z.-L.</given-names></name></person-group> (<year>2020</year>).
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat
origin</article-title>. <source><italic toggle="yes">Nature</italic></source>,
(<issue>7798</issue>),
<fpage>270</fpage>&#x02013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7,</pub-id><pub-id pub-id-type="pmid">32015507</pub-id></mixed-citation></ref></ref-list></back></article>